LENSAR Inc (LNSR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $61.47M
Last updated: Nov 17, 2026 at 11:03 AM ET
LENSAR Inc (LNSR) Stock Forecast
Analysts expect LENSAR (LNSR) to earn -$0.05 per share in the fiscal year ending Dec 31, 2026, on revenue of $60.89M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 19.4%.
- Fiscal year ending Dec 31, 2026
- -$0.05
- EPS consensus, revenue $60.89M
- Fiscal year ending Dec 31, 2027
- -$0.51
- EPS consensus, revenue $72.72M
- Next report
- Feb 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.05 | -$0.05 to -$0.05 | 1 | $60.89M | $60.00M to $61.66M | 3 |
| Dec 31, 2027 | -$0.51 | -$0.51 to -$0.51 | 1 | $72.72M | $68.00M to $81.15M | 3 |
Quarterly Estimates
The EPS consensus falls from -$0.09 for the quarter ending Dec 31, 2026 to -$0.17 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.09 | -$0.10 to -$0.07 | 5 | $17.20M | $15.68M to $18.48M | 5 |
| Mar 31, 2027 | -$0.17 | -$0.17 to -$0.17 | 1 | $15.80M | $14.80M to $17.60M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has turned from a profit of $1.87 to a loss.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.05 | N/A | N/A | $1.87 | $1.87 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.51 | N/A | N/A | -$0.72 | -$0.72 | N/A |
Frequently Asked Questions About LNSR
What is the LNSR stock forecast?
Consensus analyst estimates put LENSAR's EPS at -$0.05 for the fiscal year ending Dec 31, 2026, on revenue of $60.89M. The consensus rating from 3 analysts is Buy.
How do analysts rate LNSR stock?
Of 3 analysts covering LENSAR, 0 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from LNSR next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.05, with estimates from -$0.05 to -$0.05 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.51, with estimates from -$0.51 to -$0.51 from 1 analyst.
What revenue do analysts expect from LENSAR next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $60.89M, with estimates from $60.00M to $61.66M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $72.72M, with estimates from $68.00M to $81.15M.
How many analysts cover LNSR?
3 analysts rate LENSAR stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
LNSR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors